Clinical Trials in Philadelphia

Showing 5061-5080 of 15,860 trials

Developing Oral LT3 Therapy for Heart Failure - HFrEF

NCT04112316

Investigation of the safety, feasibility, and preliminary efficacy of thyroid hormone therapy with Liothyronine (LT3) in individuals with heart failure with reduced ejection fraction (HFrEF) and low triiodothyronine (T3) syndrome by conducting a randomized, double-blind, placebo-controlled cross-over study with a two-week washout period between treatments.

Heart Failure With Reduced Ejection Fraction (HFrEF)Low T3 Syndrome

University of Pennsylvania28 participantsStarted Feb 2020

Philadelphia, Pennsylvania, United States

RECRUITINGPhase 2< 1 mile

Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx Cancer

NCT05800574

This is a prospective, phase II, stratified single arm investigation for favorable prognosis in p16+ oropharynx cancer patients with either node negative or malignant neck adenopathy with lymphoscintigraphy mapping confined to the ipsilateral neck.

Oropharynx Cancer

Fox Chase Cancer Center22 participantsStarted Mar 2023

Philadelphia, Pennsylvania, United States

COMPLETEDPhase 1< 1 mile

Dendritic Cell Vaccination in Patients With Advanced Melanoma

NCT03092453

The purpose of this study is to investigate a method of using dendritic cells (a kind of white blood cell) as a vaccine to stimulate your own immune system to react to your melanoma cells.

Melanoma

University of Pennsylvania5 participantsStarted May 2017

Philadelphia, Pennsylvania, United States

Developing Oral LT3 Therapy for Heart Failure - HFrEF

Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx Cancer

Dendritic Cell Vaccination in Patients With Advanced Melanoma

Find Trials by Condition in Philadelphia

Opioid-Free Anesthetic for Tonsillectomy

Improving Sleep, Decision-Making, and Eating in Adolescents with Obesity

Phase 2 Open-label Extension Study of AOC 1020 in Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)

MP-376 (Aeroquin™, Levofloxacin for Inhalation) in Patients With Cystic Fibrosis

Chimney EndoVascular Aneurysm Sealing Of New Expanded Indication

Mindfulness-Based Relapse Prevention to Improve Medication Assisted Treatment Adherence and Drug-use Outcomes for Opioid Use Disorder

Durvalumab Followed by Chemoradiation and Consolidation Durvalumab for Stage III Non-small Cell Lung Cancer

CYPRESS Efficacy and Safety Study Extension

Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors

Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years

Use of Control-IQ Technology 2.0 in Adults, Children, and Preschoolers With Type 1 Diabetes

MATRIX-002: Trial to Assess Acceptability and Safety of Two Placebo Vaginal Films

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

Study of Capivasertib in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Global Fenestrated Anaconda Clinical STudy